TY - JOUR
T1 - Prevalence of UTI and its association with glycemic levels, common uropathogens involved, and antibiotic resistance among diabetic patients
AU - Kassab, Yaman Walid
AU - Aldahoul, Hiba Khaled
AU - Humayra, Syeda
AU - Saad, Eldowaik Mohamed Salah
AU - Iqbal, Muhammad Zahid
AU - Naqvi, Atta Abbas
AU - Al-Saikhan, Fahad I.
AU - Albassam, Ahmed A.
AU - Iqbal, Muhammad Shahid
N1 - Publisher Copyright:
© 2020, Colegio de Farmaceuticos de la Provincia de Buenos Aires. All rights reserved.
PY - 2020
Y1 - 2020
N2 - Diabetes mellitus (DM) is an important medical and public health issue world widely. The in-cidence has been exponentially increased in the majority of developing countries. Evidence revealed that diabetics are more prone to infections than non-diabetic patients. UTI is one of the infections that occurs more frequently among DM patients. This cross-sectional study aimed to assess the prevalence of UTI among DM patients, common uropathogens involved, and antibiotic resistance patterns. The target popu-lation was DM patients in Malaysia. A total of 348 DM patients were randomly selected as subjects for this study. This study was carried out using a purpose-developed data collection form to collect information about the patient’s demographic characteristics, medication prescribed for DM, comorbidities, glycaemic control status, occurrence and type of UTI, uropathogens identified in culture and sensitivity and antibiotics prescribed for the treatment of UTI. The prevalence of UTI among DM patients was 40.2%. Further-more, the prevalence among females was higher than males and UTIs ware significantly associated (p < 0.05) with poorly controlled glycemia. Cystitis was the most prevalent UTI. The most common uropathogen identified from the urine of DM patients was Escherichia coli. Resistance patterns showed that most bacteria developed resistance against ampicillin, TMP/SMX, and cefotaxime. Cephalosporins were the most commonly prescribed antibiotics followed by penicillins. This study determined the prevalence of UTI, antimicrobial susceptibility, common uropathogens involved, and antibiotic resistance among diabetic patients.
AB - Diabetes mellitus (DM) is an important medical and public health issue world widely. The in-cidence has been exponentially increased in the majority of developing countries. Evidence revealed that diabetics are more prone to infections than non-diabetic patients. UTI is one of the infections that occurs more frequently among DM patients. This cross-sectional study aimed to assess the prevalence of UTI among DM patients, common uropathogens involved, and antibiotic resistance patterns. The target popu-lation was DM patients in Malaysia. A total of 348 DM patients were randomly selected as subjects for this study. This study was carried out using a purpose-developed data collection form to collect information about the patient’s demographic characteristics, medication prescribed for DM, comorbidities, glycaemic control status, occurrence and type of UTI, uropathogens identified in culture and sensitivity and antibiotics prescribed for the treatment of UTI. The prevalence of UTI among DM patients was 40.2%. Further-more, the prevalence among females was higher than males and UTIs ware significantly associated (p < 0.05) with poorly controlled glycemia. Cystitis was the most prevalent UTI. The most common uropathogen identified from the urine of DM patients was Escherichia coli. Resistance patterns showed that most bacteria developed resistance against ampicillin, TMP/SMX, and cefotaxime. Cephalosporins were the most commonly prescribed antibiotics followed by penicillins. This study determined the prevalence of UTI, antimicrobial susceptibility, common uropathogens involved, and antibiotic resistance among diabetic patients.
KW - Antibiotics
KW - Antibiotics resistance
KW - Diabetes mellitus
KW - Malaysia
KW - Uropathogens
KW - UTI
UR - http://www.scopus.com/inward/record.url?scp=85089837689&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:85089837689
SN - 0326-2383
VL - 39
SP - 1840
EP - 1847
JO - Latin American Journal of Pharmacy
JF - Latin American Journal of Pharmacy
IS - 9
ER -